Back to results
US 2017/0246256 A1Published application
Methods of administering hepcidin
AssigneeLa Jolla Pharmaceutical Company
InventorsGeorge Tidmarsh, Lakhmir Chawla
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to the use of hepcidin in therapeutic methods for the treatment of various conditions in which decreasing serum iron concentration may be beneficial.
Claims39
A method for treating a condition in a subject, comprising administering a composition comprising hepcidin to the subject.
2-3. (canceled)
(canceled)
10-13. (canceled)
(canceled)
20-22. (canceled)
30-43. (canceled)
(canceled)
A method of preventing drug resistance in a subject with malaria, comprising administering to the subject an antimalarial drug and a composition comprising hepcidin.
Dependencies are inferred from the claim text.